Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | AC007557.5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC010731.4 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | AC011043.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | AC011841.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | AC015688.3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | AC023491.2 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | AC024361.1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |